Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Greece omnitrope 10 mg 1 5 ml 5 cartridges price?Zoledronic acid patent expiration date?Methylprednisolone sodium succinate hikma pharmaceuticals?Zolpidem tartrate cost without insurance?Norditropin pens for sale?
See the DrugPatentWatch profile for prolia
Prolia has been available for several years. It was approved for use in the U.S. in 2010 for osteoporosis, putting it on the market starting in that year [1].
Prolia’s U.S. approval in 2010 means it entered the osteoporosis market before many newer follow-on treatments, which have often come later as biologics and patent-protected therapies expanded. Its key “time on market” anchor is that 2010 launch/approval date [1].
The core “on the market” timeline is still measured from its first approval; additional label expansions or new indications can come later, but they do not change when the product first entered the market. Prolia’s first U.S. approval year remains 2010 [1].
[1] https://www.drugpatentwatch.com/patent/Prolia
Other Questions About Prolia :